Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Director departure
Appointed director
Vanda Pharmaceuticals Inc. (VNDA)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/21/2023
8-K
Other Events Interactive Data
07/27/2023
8-K
Quarterly results
Docs:
"
Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results
"
06/08/2023
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
05/11/2023
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
Corporate Contact:
"
03/17/2023
8-K
Appointed a new director
Docs:
"
Vanda Pharmaceuticals Appoints Dr. Tage
"
03/13/2023
8-K
Regulation FD Disclosure Interactive Data
02/08/2023
8-K
Quarterly results
12/22/2022
8-K
Other Events Interactive Data
12/16/2022
8-K
Quarterly results
12/14/2022
8-K
Quarterly results
11/02/2022
8-K
Quarterly results
08/03/2022
8-K
Quarterly results
Docs:
"
Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results
"
06/16/2022
8-K
Quarterly results
05/05/2022
8-K
Quarterly results
03/01/2022
8-K
Quarterly results
02/23/2022
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
"
02/04/2022
8-K
Quarterly results
01/14/2022
8-K
Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data
Docs:
"
Vanda Pharmaceuticals Settles HETLIOZ ® Patent Litigation with MSN
"
11/03/2021
8-K
Quarterly results
Docs:
"
Vanda Pharmaceuticals Reports Third Quarter 2021 Financial Results
"
10/08/2021
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
07/28/2021
8-K
Quarterly results
Docs:
"
Vanda Pharmaceuticals Reports Second Quarter 2021 Financial Results
"
06/10/2021
8-K
Quarterly results
05/05/2021
8-K
Quarterly results
02/25/2021
8-K
Quarterly results
02/10/2021
8-K
Quarterly results
12/02/2020
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
FDA Approves HETLIOZ ® for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome
"
10/28/2020
8-K
Quarterly results
Docs:
"
Vanda Pharmaceuticals Reports Third Quarter 2020 Financial Results
"
08/18/2020
8-K
Quarterly results
08/05/2020
8-K
Quarterly results
07/29/2020
8-K
Quarterly results
06/11/2020
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
05/26/2020
8-K
Other Events, Financial Statements and Exhibits Interactive Data
Docs:
"
Vanda Pharmaceuticals Announces Virtual 2020 Stockholder Meeting
"
05/13/2020
8-K
Quarterly results
05/06/2020
8-K
Quarterly results
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy